niets over ruconest voor ukkie's.
19/06/2018 Opinion/decision on a Paediatric investigation plan (PIP): -,
Plazomicin (sulfate)
Therapeutic area: Infectious diseases
19/06/2018 Opinion/decision on a Paediatric investigation plan (PIP): -,
Treprostinil (sodium)
Therapeutic area: Cardiovascular diseases
19/06/2018 Opinion/decision on a Paediatric investigation plan (PIP): -,
Non-pathogenic bacterial lysate of Escherichia coli and Enterococcus faecalis
Therapeutic area: Gastroentology-Hepatology
19/06/2018 Opinion/decision on a Paediatric investigation plan (PIP): -,
Levothyroxine (sodium)
Therapeutic area: Endocrinology, -gynacology-fertility-metabolism
19/06/2018 Opinion/decision on a Paediatric investigation plan (PIP): -,
Vamorolone
Therapeutic area: Other
19/06/2018 Opinion/decision on a Paediatric investigation plan (PIP): -,
Candesartan (cilexetil) / amlodipine (besylate)
Therapeutic area: Cardiovascular diseases
19/06/2018 Opinion/decision on a Paediatric investigation plan (PIP): -,
Tanezumab
Therapeutic area: Pain
19/06/2018 Opinion/decision on a Paediatric investigation plan (PIP): -,
Pemafibrate
Therapeutic area: Cardiovascular diseases/Endocrinology, -gynacology-fertility-metabolism
19/06/2018 Opinion/decision on a Paediatric investigation plan (PIP): Vandaag,
Anifrolumab
Therapeutic area: Immunology-Rheumatology-Transplantation
19/06/2018 Opinion/decision on a Paediatric investigation plan (PIP): -,
Fluticasone furoate / umeclidinium bromide / vilanterol trifenatate
Therapeutic area: Pneumology-allergology
19/06/2018 Opinion/decision on a Paediatric investigation plan (PIP): -,
Tremelimumab
Therapeutic area: Oncology
19/06/2018 Opinion/decision on a Paediatric investigation plan (PIP): -,
Durvalumab
Therapeutic area: Oncology
19/06/2018 Opinion/decision on a Paediatric investigation plan (PIP): -,
Tralokinumab
Therapeutic area: Dermatology
19/06/2018 Opinion/decision on a Paediatric investigation plan (PIP): -,
Humanized recombinant IgG4 anti-human tau antibody
Therapeutic area: Neurology
19/06/2018 Opinion/decision on a Paediatric investigation plan (PIP): -,
Crizanlizumab
Therapeutic area:
19/06/2018 Opinion/decision on a Paediatric investigation plan (PIP): -,
Adeno-associated viral vector serotype rh.10 carrying the human
Nsulfoglucosamine
Nsulfoglucosamine sulfohydrolase cDNA (LYS-SAF302)
Therapeutic area: Neurology
19/06/2018 Opinion/decision on a Paediatric investigation plan (PIP): -,
(RS)-Bacoflen / Naltrexone HCl / D-Sorbitol (PXT3003)
Therapeutic area: Neurology
19/06/2018 Opinion/decision on a Paediatric investigation plan (PIP): -,
Pevonedistat
Therapeutic area: Oncology
19/06/2018 Opinion/decision on a Paediatric investigation plan (PIP): -,
Dapagliflozin / saxagliptin / metformin (hydrochloride)
Therapeutic area: Endocrinology, -gynacology-fertility-metabolism
19/06/2018 Opinion/decision on a Paediatric investigation plan (PIP): -,
Rosuvastatin / ezetimibe
Therapeutic area: Cardiovascular diseases
19/06/2018 Opinion/decision on a Paediatric investigation plan (PIP): -,
Trazodone (hydrochloride) / gabapentin
Therapeutic area: Pain
19/06/2018 Opinion/decision on a Paediatric investigation plan (PIP): -,
Niraparib
Therapeutic area: Oncology
19/06/2018 Opinion/decision on a Paediatric investigation plan (PIP): -,
Insulin human (NTRA-2112)
Therapeutic area: Gastroentology-Hepatology
19/06/2018 Opinion/decision on a Paediatric investigation plan (PIP): -,
T-cell bispecific antibody targeting carcinoembryonic antigen expressed on tumor cells and CD3 epsilon chain present on T-cells
Therapeutic area: Oncology
19/06/2018 Opinion/decision on a Paediatric investigation plan (PIP): -,
Entinostat Polymorph B
Therapeutic area: Oncology
19/06/2018 Opinion/decision on a Paediatric investigation plan (PIP): -,
dapagliflozin / metformin (hydrochloride)
Therapeutic area: Endocrinology, -gynacology-fertility-metabolism
19/06/2018 Opinion/decision on a Paediatric investigation plan (PIP): Jakavi,
Ruxolitinib (phosphate)
Therapeutic area: Oncology
19/06/2018 Opinion/decision on a Paediatric investigation plan (PIP): -,
Veliparib
Therapeutic area: Oncology
19/06/2018 Opinion/decision on a Paediatric investigation plan (PIP): -,
Venglustat
Therapeutic area: Endocrinology, -gynacology-fertility-metabolism